A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy

C Mazzaro, L Quartuccio, LE Adinolfi, D Roccatello… - Viruses, 2021 - mdpi.com
Extrahepatic manifestations are a feature of chronic hepatitis C virus (HCV) infection. In the
course of chronic HCV infection, about 70% of patients have one or more extrahepatic …

[HTML][HTML] Chronic pain and infection: mechanisms, causes, conditions, treatments, and controversies

SP Cohen, EJ Wang, TL Doshi, L Vase, KA Cawcutt… - BMJ …, 2022 - ncbi.nlm.nih.gov
Throughout human history, infection has been the leading cause of morbidity and mortality,
with pain being one of the cardinal warning signs. However, in a substantial percentage of …

Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality

M Higuchi, N Tamaki, M Kurosaki… - Alimentary …, 2022 - Wiley Online Library
Background Magnetic resonance elastography (MRE) has the highest diagnostic accuracy
for liver fibrosis; however, the association between MRE‐associated liver stiffness and the …

Burden, Outcome, and comorbidities of Extrahepatic manifestations in Hepatitis C virus Infection

B Songtanin, K Nugent - Biology, 2022 - mdpi.com
Simple Summary Hepatitis C is a liver infection caused by the hepatitis C virus and is a
major health problem that contributes to the global burden of chronic disease. Chronic …

Cardiovascular implications of immune disorders in women

CA Moran, LF Collins, N Beydoun, PK Mehta… - Circulation …, 2022 - Am Heart Assoc
Immune responses differ between men and women, with women at higher risk of developing
chronic autoimmune diseases and having more robust immune responses to many viruses …

[HTML][HTML] Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions

J Leslie, D Geh, AM Elsharkawy, DA Mann… - Journal of hepatology, 2022 - Elsevier
Hepatitis C virus hijacks many host metabolic processes in an effort to aid viral replication.
The resulting hepatic metabolic dysfunction underpins many of the hepatic and extrahepatic …

Direct-acting antivirals as primary treatment for hepatitis C virus–associated indolent non-Hodgkin lymphomas: the BArT study of the fondazione italiana linfomi

M Merli, S Rattotti, M Spina, F Re, M Motta… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE We prospectively treated patients with hepatitis C virus (HCV)–associated
indolent lymphomas with genotype-appropriate direct-acting antivirals (DAAs) with the aim …

Society for Maternal-Fetal Medicine consult series# 56: hepatitis C in pregnancy—updated guidelines: replaces consult number 43, November 2017

SK Dotters-Katz, JA Kuller, BL Hughes… - American Journal of …, 2021 - Elsevier
In the United States, it is estimated that 1% to 4% of pregnant women are infected with
hepatitis C virus, which carries approximately a 5% risk of transmission from mother to infant …

Extrahepatic manifestations of chronic HBV infection and the role of antiviral therapy

C Mazzaro, LE Adinolfi, G Pozzato, R Nevola… - Journal of clinical …, 2022 - mdpi.com
The hepatitis B virus (HBV) infection leads to chronic hepatitis, cirrhosis, and
hepatocarcinoma. However, about 20% of patients experience extrahepatic manifestations …

Impact of DAA treatment on cardiovascular disease risk in chronic HCV infection: an update

H Roguljic, V Nincevic, K Bojanic, L Kuna… - Frontiers in …, 2021 - frontiersin.org
Hepatitis C virus (HCV) infection is a systemic disease associated with multiple significant
extrahepatic manifestations. Emerging studies indicate association between the HCV …